Roche pursues partnering approach in shifting Asian landscape
This article was originally published in Scrip
Executive Summary
Roche expects to do its biggest ever number of licensing and technology deals in 2008. But despite the figure, which will approach 50, "we are staying firmly focused on first-in-class innovation and medically differentiated products", maintains Dan Zabrowski, the company's global head of pharma partnering.